Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (393)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
489
8.250
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
83
3.510
 Why?
Immunologic Factors
13
2025
260
2.380
 Why?
Neurology
10
2018
117
2.140
 Why?
Immunosuppressive Agents
10
2024
838
1.520
 Why?
Neuromyelitis Optica
4
2023
140
1.070
 Why?
Natalizumab
11
2021
41
0.890
 Why?
Recurrence
8
2025
1139
0.840
 Why?
Diagnostic Errors
2
2017
178
0.660
 Why?
Brain
16
2025
2969
0.640
 Why?
Internship and Residency
5
2011
1269
0.610
 Why?
Drug Substitution
2
2019
63
0.610
 Why?
Fingolimod Hydrochloride
5
2020
40
0.600
 Why?
Rituximab
4
2020
210
0.560
 Why?
Data Collection
4
2011
643
0.560
 Why?
Magnetic Resonance Imaging
25
2026
3916
0.560
 Why?
Dementia, Vascular
3
2009
21
0.550
 Why?
Medication Adherence
2
2019
540
0.510
 Why?
Early Medical Intervention
1
2017
63
0.500
 Why?
Early Diagnosis
2
2017
251
0.490
 Why?
Glatiramer Acetate
6
2019
18
0.470
 Why?
Calcinosis
2
2009
234
0.460
 Why?
Humans
88
2026
145783
0.460
 Why?
Drug Monitoring
1
2019
401
0.450
 Why?
Physicians
4
2016
956
0.450
 Why?
Postural Balance
3
2018
247
0.420
 Why?
Antibodies, Monoclonal, Humanized
8
2023
992
0.390
 Why?
Neuroimaging
2
2026
300
0.360
 Why?
Fatigue
3
2018
366
0.360
 Why?
Dimethyl Fumarate
3
2020
12
0.350
 Why?
Immunoglobulin G
4
2023
892
0.340
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
28
0.310
 Why?
Practice Guidelines as Topic
1
2018
1582
0.310
 Why?
Middle Aged
39
2025
36309
0.310
 Why?
Withholding Treatment
2
2021
80
0.300
 Why?
Adult
44
2026
40881
0.300
 Why?
Psychiatry
2
2009
195
0.280
 Why?
Cysts
1
2009
112
0.270
 Why?
Demyelinating Diseases
4
2019
84
0.270
 Why?
HIV Long Terminal Repeat
3
2001
12
0.270
 Why?
Autoantibodies
3
2023
1509
0.260
 Why?
Education, Medical
1
2011
276
0.260
 Why?
Lymphopenia
2
2020
62
0.250
 Why?
Certification
1
2008
119
0.250
 Why?
Education
2
2007
105
0.250
 Why?
Central Nervous System Cysts
1
2006
13
0.250
 Why?
Female
49
2025
79045
0.240
 Why?
Cerebral Arteries
1
2006
59
0.240
 Why?
Clinical Trials as Topic
3
2016
1062
0.240
 Why?
Leukoencephalopathies
1
2026
24
0.240
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
55
0.240
 Why?
Single-Blind Method
3
2023
318
0.230
 Why?
Male
40
2025
73011
0.230
 Why?
Cerebrovascular Disorders
1
2006
105
0.230
 Why?
DNA, Viral
2
1998
356
0.230
 Why?
Drug Industry
2
2016
49
0.220
 Why?
Ethics, Medical
2
2015
91
0.220
 Why?
Societies, Medical
4
2019
900
0.220
 Why?
HIV Seropositivity
2
1998
119
0.220
 Why?
Conflict of Interest
2
2016
54
0.220
 Why?
Treatment Outcome
12
2023
11794
0.210
 Why?
White Matter
1
2026
155
0.210
 Why?
Databases, Factual
3
2016
1491
0.200
 Why?
Double-Blind Method
4
2023
2064
0.200
 Why?
AIDS Dementia Complex
3
2001
52
0.200
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
69
0.190
 Why?
Microglia
2
2024
273
0.190
 Why?
Heart Aneurysm
1
2002
12
0.180
 Why?
Quality of Health Care
2
2017
693
0.170
 Why?
Heart Septal Defects, Atrial
1
2002
58
0.170
 Why?
B-Lymphocytes
5
2023
872
0.170
 Why?
Interferon beta-1a
2
2019
14
0.170
 Why?
Lymphoma
2
2005
241
0.170
 Why?
Education, Medical, Continuing
2
2015
134
0.160
 Why?
Mental Disorders
2
2007
1171
0.160
 Why?
Central Nervous System Neoplasms
2
2005
177
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Brain Neoplasms
4
2016
1331
0.160
 Why?
Interferon-gamma
1
2023
784
0.150
 Why?
Serum Sickness
1
2019
4
0.150
 Why?
Indans
1
2019
13
0.150
 Why?
Oxadiazoles
1
2019
37
0.150
 Why?
Neutropenia
1
2020
154
0.150
 Why?
Disease Progression
4
2021
2865
0.150
 Why?
Diagnosis, Differential
4
2023
1512
0.150
 Why?
Referral and Consultation
1
2005
869
0.140
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.140
 Why?
Adjuvants, Immunologic
3
2015
244
0.130
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
261
0.130
 Why?
Salvage Therapy
1
2019
165
0.130
 Why?
Herpesvirus 8, Human
1
1998
67
0.130
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.130
 Why?
Eye Movements
1
2018
94
0.130
 Why?
Physician-Patient Relations
2
2016
588
0.130
 Why?
Educational Measurement
3
2015
326
0.130
 Why?
Sarcoma, Kaposi
1
1998
83
0.130
 Why?
Central Nervous System
2
2005
282
0.130
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
699
0.120
 Why?
Herpesvirus 4, Human
1
2018
172
0.120
 Why?
Young Adult
7
2024
14254
0.120
 Why?
Patient Selection
2
2015
739
0.120
 Why?
Herpesviridae Infections
1
1998
148
0.120
 Why?
Nervous System Diseases
2
2024
286
0.120
 Why?
Suicide, Assisted
1
1997
31
0.120
 Why?
Neurologists
1
2016
23
0.120
 Why?
Costs and Cost Analysis
1
2017
221
0.120
 Why?
Estriol
1
2015
6
0.120
 Why?
Cost-Benefit Analysis
2
2016
644
0.120
 Why?
Aged
9
2024
26217
0.110
 Why?
Corpus Callosum
2
2006
72
0.110
 Why?
Verbal Learning
2
2013
72
0.110
 Why?
Dizziness
2
2018
101
0.110
 Why?
T-Lymphocytes
1
2023
1998
0.110
 Why?
Retrospective Studies
10
2024
17330
0.110
 Why?
Follow-Up Studies
6
2020
5428
0.100
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
156
0.100
 Why?
Trust
1
2016
158
0.100
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
59
0.100
 Why?
Medication Reconciliation
1
2013
32
0.100
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
132
0.100
 Why?
CD40 Antigens
1
2014
90
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Insurance, Health
1
2016
311
0.100
 Why?
Exercise Therapy
1
2018
475
0.090
 Why?
Anti-Inflammatory Agents
2
2006
478
0.090
 Why?
Stroke
1
2002
1271
0.090
 Why?
Sensation Disorders
1
2012
40
0.090
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
20
0.090
 Why?
Population Surveillance
1
2016
484
0.090
 Why?
Memory Disorders
1
2013
197
0.090
 Why?
Immunoglobulin Heavy Chains
3
2007
86
0.090
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.090
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
20
0.090
 Why?
HIV-1
2
2001
908
0.090
 Why?
Optic Nerve
2
2005
67
0.090
 Why?
T-Lymphocyte Subsets
1
2014
420
0.090
 Why?
Glioma
1
2016
429
0.080
 Why?
Gadolinium
4
2018
84
0.080
 Why?
Academies and Institutes
1
2011
61
0.080
 Why?
United States
8
2024
16126
0.080
 Why?
Self-Assessment
1
2011
74
0.080
 Why?
Learning
1
2015
444
0.080
 Why?
Nerve Regeneration
1
2010
58
0.080
 Why?
Fatal Outcome
3
2006
305
0.080
 Why?
Diagnostic Tests, Routine
1
2011
107
0.080
 Why?
Leukocytosis
1
2010
32
0.080
 Why?
Antigens, CD19
3
2007
128
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
8
0.080
 Why?
Hemangioma, Cavernous
1
1989
13
0.080
 Why?
Optic Chiasm
1
1989
19
0.080
 Why?
Exercise Test
1
2012
630
0.080
 Why?
Biomarkers
3
2014
4302
0.070
 Why?
Central Nervous System Infections
1
2010
35
0.070
 Why?
Severity of Illness Index
3
2014
2933
0.070
 Why?
Quality of Life
3
2021
3211
0.070
 Why?
Disease Management
1
2013
653
0.070
 Why?
Guidelines as Topic
1
2011
268
0.070
 Why?
Spinal Cord
3
2023
382
0.070
 Why?
Neuroprotective Agents
1
2009
148
0.070
 Why?
Physical Therapy Modalities
1
2011
337
0.070
 Why?
Hospital-Physician Relations
1
2007
4
0.060
 Why?
Immunoglobulin Variable Region
2
2004
80
0.060
 Why?
Practice Patterns, Physicians'
1
2016
1372
0.060
 Why?
Workload
1
2009
169
0.060
 Why?
Vasculitis, Central Nervous System
1
2006
16
0.060
 Why?
Headache Disorders
1
2006
19
0.060
 Why?
Nerve Fibers, Myelinated
1
2006
47
0.060
 Why?
Neuropsychological Tests
2
2013
1137
0.060
 Why?
CD4-Positive T-Lymphocytes
1
1993
1146
0.060
 Why?
Antibodies, Monoclonal
2
2011
1505
0.060
 Why?
Methylprednisolone
1
2006
59
0.060
 Why?
Medical Records
1
2007
192
0.060
 Why?
Syndrome
2
2023
381
0.060
 Why?
Antibody Formation
1
2007
288
0.060
 Why?
Huntington Disease
1
2007
61
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
122
0.060
 Why?
International Classification of Diseases
1
2007
150
0.060
 Why?
Herpes Zoster
1
2010
319
0.060
 Why?
Contrast Media
3
2018
497
0.060
 Why?
Intracranial Hemorrhages
1
2006
106
0.060
 Why?
Aquaporin 4
1
2006
101
0.060
 Why?
DNA Mutational Analysis
1
2006
410
0.060
 Why?
Adolescent
8
2024
22577
0.060
 Why?
Canada
2
2019
432
0.060
 Why?
Health Care Surveys
1
2007
536
0.060
 Why?
Analysis of Variance
3
2015
1300
0.050
 Why?
Patient Compliance
1
2009
588
0.050
 Why?
Neurologic Examination
1
2005
132
0.050
 Why?
Fellowships and Scholarships
1
2009
354
0.050
 Why?
Cognition Disorders
1
2009
544
0.050
 Why?
Teaching
1
2007
237
0.050
 Why?
RNA, Messenger
1
1992
2805
0.050
 Why?
Program Evaluation
1
2009
944
0.050
 Why?
Surveys and Questionnaires
4
2016
6085
0.050
 Why?
Colorado
2
2024
4556
0.050
 Why?
Central Nervous System Diseases
1
2005
74
0.050
 Why?
Affect
1
2007
321
0.050
 Why?
Neutrophils
1
2010
1127
0.050
 Why?
Simvastatin
1
2004
59
0.050
 Why?
Erythrocytes
1
2010
749
0.050
 Why?
Ophthalmoplegia
1
2003
13
0.050
 Why?
Proteoglycans
1
2004
112
0.050
 Why?
Prevalence
2
2024
2875
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
53
0.050
 Why?
Faculty, Medical
1
2006
305
0.050
 Why?
B-Lymphocyte Subsets
1
2003
76
0.050
 Why?
Cyclophosphamide
1
2003
272
0.050
 Why?
Radiography
1
2005
853
0.050
 Why?
Neurodegenerative Diseases
1
2024
143
0.050
 Why?
Patient Outcome Assessment
1
2023
130
0.040
 Why?
Infusions, Intravenous
1
2023
428
0.040
 Why?
Academic Medical Centers
1
2005
554
0.040
 Why?
Membrane Glycoproteins
1
2004
499
0.040
 Why?
Students, Medical
1
2006
378
0.040
 Why?
Induced Pluripotent Stem Cells
1
2024
273
0.040
 Why?
Lymphoma, B-Cell
2
2005
141
0.040
 Why?
Molecular Sequence Data
3
2004
2883
0.040
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
37
0.040
 Why?
Pain
1
2007
791
0.040
 Why?
Disability Evaluation
2
2014
311
0.040
 Why?
Anticoagulants
1
2006
748
0.040
 Why?
Single-Cell Analysis
1
2024
361
0.040
 Why?
Antibodies, Antinuclear
1
2001
62
0.040
 Why?
Schools, Medical
1
2002
159
0.040
 Why?
Peptides
3
2013
999
0.040
 Why?
Cross-Sectional Studies
1
2012
5925
0.040
 Why?
Atrophy
1
2021
199
0.040
 Why?
Time Factors
4
2018
7134
0.040
 Why?
Dementia
1
2005
328
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
155
0.040
 Why?
Mobility Limitation
1
2020
67
0.040
 Why?
Clinical Competence
1
2008
1247
0.040
 Why?
Venous Thrombosis
1
2002
196
0.040
 Why?
Child
5
2016
22740
0.040
 Why?
Interferon-beta
2
2011
92
0.040
 Why?
Lymphocyte Activation
1
2003
1133
0.040
 Why?
Antibodies, Viral
1
2023
674
0.040
 Why?
Maintenance Chemotherapy
1
2019
42
0.040
 Why?
Cell Separation
2
2014
306
0.040
 Why?
Cerebral Infarction
1
1998
47
0.030
 Why?
Induction Chemotherapy
1
2019
88
0.030
 Why?
Lipids
1
2023
707
0.030
 Why?
HIV Seronegativity
1
1998
29
0.030
 Why?
Base Sequence
2
2001
2171
0.030
 Why?
Genes, myc
1
1998
51
0.030
 Why?
Transplantation, Autologous
1
2019
301
0.030
 Why?
Astrocytoma
1
1998
130
0.030
 Why?
In Situ Hybridization
1
2018
318
0.030
 Why?
Gene Library
1
1997
122
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
337
0.030
 Why?
Gene Rearrangement
1
1998
156
0.030
 Why?
Risk Assessment
1
2006
3752
0.030
 Why?
Managed Care Programs
1
1997
140
0.030
 Why?
Syndecan-1
2
2007
43
0.030
 Why?
Drug Administration Schedule
1
2018
782
0.030
 Why?
Morals
1
1997
79
0.030
 Why?
Flow Cytometry
2
2014
1165
0.030
 Why?
Breast Neoplasms
1
2008
2393
0.030
 Why?
Viral Load
1
2018
526
0.030
 Why?
Risk Factors
3
2008
10919
0.030
 Why?
Mutation
1
2006
4090
0.030
 Why?
Polymerase Chain Reaction
1
1998
1043
0.030
 Why?
Survival Analysis
1
2018
1378
0.030
 Why?
Sequence Analysis, DNA
1
1997
778
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1420
0.030
 Why?
Child, Preschool
3
2016
11868
0.020
 Why?
Incidence
1
2020
2934
0.020
 Why?
Congresses as Topic
1
2015
224
0.020
 Why?
Propylene Glycols
1
2013
28
0.020
 Why?
Ocular Physiological Phenomena
1
1992
10
0.020
 Why?
HLA-DR Antigens
1
2014
220
0.020
 Why?
Patient Care Team
1
2019
697
0.020
 Why?
Sphingosine
1
2013
47
0.020
 Why?
beta-Galactosidase
1
1992
76
0.020
 Why?
Quality-Adjusted Life Years
1
2013
125
0.020
 Why?
Drug Therapy, Combination
1
2015
1043
0.020
 Why?
Markov Chains
1
2013
132
0.020
 Why?
Mice, Inbred DBA
1
1992
182
0.020
 Why?
Leukocyte Count
1
1993
318
0.020
 Why?
Haplotypes
1
2014
500
0.020
 Why?
Organ Specificity
1
1992
309
0.020
 Why?
Reference Values
1
2013
798
0.020
 Why?
Comparative Effectiveness Research
1
2013
169
0.020
 Why?
Ki-67 Antigen
1
2012
118
0.020
 Why?
CD3 Complex
1
2012
112
0.020
 Why?
Thymus Gland
1
1992
312
0.020
 Why?
Mental Recall
1
2013
223
0.020
 Why?
Intestine, Small
1
1992
167
0.020
 Why?
Mitoxantrone
1
2011
15
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Mice
2
2023
18356
0.020
 Why?
Muscle Stretching Exercises
1
2011
19
0.020
 Why?
Animals
3
2023
38102
0.020
 Why?
Patient Participation
1
2015
446
0.020
 Why?
Clinical Laboratory Techniques
1
2011
96
0.020
 Why?
Depression
2
2011
1559
0.020
 Why?
Amino Acid Sequence
2
2004
2131
0.020
 Why?
Recombinant Fusion Proteins
1
1992
666
0.020
 Why?
Physical Endurance
1
2011
279
0.020
 Why?
Acyclovir
1
2010
98
0.020
 Why?
Spinal Cord Neoplasms
1
1989
41
0.020
 Why?
Cell Count
1
2010
319
0.020
 Why?
Respiratory Function Tests
1
2011
544
0.020
 Why?
History, 19th Century
1
2009
63
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1752
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
58
0.020
 Why?
Aged, 80 and over
2
2016
8347
0.020
 Why?
Injections
1
2009
199
0.020
 Why?
History, 21st Century
1
2009
222
0.020
 Why?
Pilot Projects
2
2004
1898
0.020
 Why?
History, 20th Century
1
2009
328
0.020
 Why?
Autoimmunity
1
2014
933
0.020
 Why?
Gene Expression
1
1992
1478
0.020
 Why?
Electrocardiography
1
2011
668
0.020
 Why?
Mice, Transgenic
1
1992
2191
0.020
 Why?
Health
1
2007
82
0.020
 Why?
Age of Onset
1
2009
557
0.020
 Why?
Memory
1
2009
297
0.020
 Why?
Association Learning
1
2007
70
0.020
 Why?
Walking
1
2011
545
0.010
 Why?
Herpesvirus 3, Human
1
2010
343
0.010
 Why?
Cerebral Ventricles
1
2006
56
0.010
 Why?
CD8-Positive T-Lymphocytes
1
2012
923
0.010
 Why?
Prognosis
2
2006
4330
0.010
 Why?
Motor Skills
1
2007
104
0.010
 Why?
Models, Theoretical
1
2009
560
0.010
 Why?
Phenotype
1
2014
3170
0.010
 Why?
Genetics
1
2005
23
0.010
 Why?
Hypothalamus
1
2006
163
0.010
 Why?
Immunologic Memory
1
2007
368
0.010
 Why?
Neurosciences
1
2005
24
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Social Support
1
2009
651
0.010
 Why?
Anisotropy
1
2004
74
0.010
 Why?
Clinical Protocols
1
2006
280
0.010
 Why?
Hospitalization
1
2015
2461
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
289
0.010
 Why?
Immune System
1
2005
180
0.010
 Why?
Internet
1
2009
693
0.010
 Why?
Plasma Cells
1
2004
80
0.010
 Why?
Antiviral Agents
1
2010
769
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
11
0.010
 Why?
Infrared Rays
1
2003
24
0.010
 Why?
Meningitis, Viral
1
2003
20
0.010
 Why?
Videotape Recording
1
2003
37
0.010
 Why?
Saccades
1
2003
46
0.010
 Why?
Antilymphocyte Serum
1
2003
57
0.010
 Why?
Oligoclonal Bands
1
2003
26
0.010
 Why?
Antigens, CD34
1
2003
90
0.010
 Why?
Clone Cells
1
2003
263
0.010
 Why?
Whole-Body Irradiation
1
2003
74
0.010
 Why?
Astrocytes
1
2005
228
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
130
0.010
 Why?
Immunoglobulins
1
2003
163
0.010
 Why?
Observer Variation
1
2003
357
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
195
0.010
 Why?
Feasibility Studies
1
2006
1115
0.010
 Why?
Mice, Inbred C57BL
1
1992
5993
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
9
0.010
 Why?
Age Factors
1
2009
3346
0.010
 Why?
Administration, Oral
1
2004
867
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2770
0.010
 Why?
Consensus Sequence
1
2001
73
0.010
 Why?
Biopsy
1
2005
1082
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
979
0.010
 Why?
Longitudinal Studies
1
2009
2968
0.010
 Why?
Sex Characteristics
1
2007
789
0.010
 Why?
Cytomegalovirus Infections
1
2003
206
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
23
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
56
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
93
0.010
 Why?
Urinary Tract Infections
1
2003
210
0.010
 Why?
Infant
1
2015
10091
0.010
 Why?
Predictive Value of Tests
1
2006
2123
0.010
 Why?
Cohort Studies
1
2011
6033
0.010
 Why?
Acute Disease
1
2003
1036
0.010
 Why?
Research
1
2003
431
0.010
 Why?
Combined Modality Therapy
1
2003
1271
0.010
 Why?
Lung
1
1992
4116
0.010
 Why?
Arachnoid
1
1998
11
0.010
 Why?
Sensitivity and Specificity
1
2003
2000
0.010
 Why?
Monocytes
1
2001
539
0.010
 Why?
Survival Rate
1
2003
2094
0.010
 Why?
Virus Replication
1
2001
521
0.010
 Why?
Models, Biological
1
2005
1764
0.010
 Why?
Binding Sites
1
2001
1311
0.010
 Why?
Case-Control Studies
1
2004
3634
0.010
 Why?
Aging
1
2007
1973
0.010
 Why?
Reproducibility of Results
1
2003
3418
0.010
 Why?
Transcription, Genetic
1
2001
1454
0.010
 Why?
DNA-Binding Proteins
1
2001
1482
0.010
 Why?
Cells, Cultured
1
2001
4151
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (393) concept(s)
_
Co-Authors Expand Description
See all (39) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)